Publication | Open Access

Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms

InflammationAnti-inflammatoryImmunologyPharmacologyAntiviral Drug DevelopmentNovel 1,4-DiarylpyranopyrazolesAntiviral TherapyPharmacotherapyDual EffectAntiviral DrugMedicineAntiviral CompoundInflammatory SymptomsDrug Discovery